SCHEMBL1389992

SCHEMBL1389992

Cc1cnc(F)cc1C(=O)CC(c1ccc(Br)cc1)c1ccccc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 3/20 0.44
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
NR3C2 P08235 1/20 0.36
CTSA P10619 7/20 0.35
PTGFR P43088 3/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390097 0.91 GPBAR1 (0.42) GPBAR1MGAMGAASIMGAM2
SCHEMBL1395402 0.86 BRD4 (0.36) MGAMGAASIMGAM2CTSA
SCHEMBL1390361 0.86 GPBAR1 (0.55) GPBAR1NR3C2CTSA
SCHEMBL1390297 0.85 GPBAR1 (0.54) GPBAR1NR3C2CTSAPTGFR
SCHEMBL362889 0.85 GPBAR1 (0.54) GPBAR1NR3C2CTSAPTGFR
SCHEMBL10241041 0.85 GPBAR1 (0.54) GPBAR1NR3C2CTSAPTGFR
SCHEMBL1390350 0.84 GPBAR1 (0.43) GPBAR1MGAMGAASIMGAM2
SCHEMBL1390144 0.84 BRD4 (0.43) CTSAHPGDLMNASMN1; SMN2NPSR1
SCHEMBL1390075 0.83 GPBAR1 (0.45) GPBAR1CTSA
SCHEMBL1390264 0.82 GPBAR1 (0.42) GPBAR1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885MGAM 2443/4885GAA 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.